ATPC
ATPC
Agape ATP CorporationIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $399.13K ▲ | $1.51M ▲ | $-376.94K ▲ | -94.44% ▲ | $-0.38 ▲ | $-1.25M ▼ |
| Q3-2025 | $370.59K ▼ | $840.42K ▼ | $-592.98K ▲ | -160.01% ▼ | $-0.59 ▲ | $-518.1K ▲ |
| Q2-2025 | $465.5K ▲ | $845.9K ▼ | $-617.08K ▲ | -132.56% ▲ | $-0.61 ▲ | $-592.73K ▲ |
| Q1-2025 | $289.04K ▼ | $876.69K ▼ | $-698.95K ▲ | -241.82% ▼ | $-9 ▲ | $-669.38K ▲ |
| Q4-2024 | $359.78K | $1.03M | $-808.44K | -224.71% | $-10 | $-779.62K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $140.07K ▲ | $24.59M ▲ | $2.17M ▲ | $22.46M ▼ |
| Q3-2025 | $133.71K ▼ | $24.39M ▼ | $1.59M ▲ | $22.83M ▼ |
| Q2-2025 | $215.97K ▼ | $24.72M ▼ | $1.31M ▲ | $23.43M ▼ |
| Q1-2025 | $578.79K ▼ | $25.18M ▲ | $1.15M ▼ | $24.05M ▲ |
| Q4-2024 | $2.04M | $3.24M | $1.31M | $1.93M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-376.07K ▲ | $-208.35K ▲ | $-382 ▼ | $201.64K ▲ | $6.36K ▲ | $-208.73K ▲ |
| Q3-2025 | $-595.37K ▲ | $-256.74K ▲ | $-7 ▲ | $181.33K ▲ | $-82.26K ▲ | $-256.75K ▲ |
| Q2-2025 | $-623.25K ▲ | $-494.46K ▲ | $-11 ▲ | $121.02K ▼ | $-362.82K ▲ | $-494.47K ▲ |
| Q1-2025 | $-712.92K ▲ | $-1.45M ▼ | $-23M ▼ | $22.99M ▲ | $-1.46M ▼ | $-1.45M ▼ |
| Q4-2024 | $-826.6K | $-645.34K | $-1.44K | $-5.17K | $-678.79K | $-646.77K |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Energized Mineral Concentrate | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Health and Wellness Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Ionized Cal Mag | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Product | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Product Health Therapies | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
5-Year Trend Analysis
A comprehensive look at Agape ATP Corporation's financial evolution and strategic trajectory over the past five years.
The company benefits from a strong reported liquidity position, minimal debt, and a sizable equity base relative to its current scale. Its products generate positive gross margins, showing that customers are willing to pay enough to cover direct costs. Strategically, its attempt to blend wellness, lifestyle, and green energy themes offers a differentiated story that could appeal to health-conscious and sustainability-focused consumers, especially if supported by a growing ecosystem of services and partnerships.
Key risks revolve around persistent operating losses, heavy cash burn, and dependence on external equity financing. The cost structure is misaligned with current revenue, and asset quality is somewhat opaque due to large “other current assets” and limited cash. Competitive and execution risks are also high: ATPC operates in saturated, fast-moving markets against larger rivals, while simultaneously managing governance issues, dilution, and prior listing-compliance concerns. A lack of identifiable, well-funded R&D and limited evidence of proprietary technology further constrain its long-term moat.
Looking ahead, ATPC’s trajectory will largely depend on its ability to scale revenue meaningfully, rationalize its operating costs, and convert its wellness and green energy initiatives into stable, cash-generating businesses. The solid balance sheet foundation provides some runway, but continued losses and cash outflows will gradually erode that cushion if not addressed. The outlook is therefore highly execution-sensitive: there is room for upside if the strategy takes hold and financial discipline improves, but current fundamentals point to a challenging path that will require careful management and sustained access to capital.
About Agape ATP Corporation
https://www.agapeatpgroup.comAgape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $399.13K ▲ | $1.51M ▲ | $-376.94K ▲ | -94.44% ▲ | $-0.38 ▲ | $-1.25M ▼ |
| Q3-2025 | $370.59K ▼ | $840.42K ▼ | $-592.98K ▲ | -160.01% ▼ | $-0.59 ▲ | $-518.1K ▲ |
| Q2-2025 | $465.5K ▲ | $845.9K ▼ | $-617.08K ▲ | -132.56% ▲ | $-0.61 ▲ | $-592.73K ▲ |
| Q1-2025 | $289.04K ▼ | $876.69K ▼ | $-698.95K ▲ | -241.82% ▼ | $-9 ▲ | $-669.38K ▲ |
| Q4-2024 | $359.78K | $1.03M | $-808.44K | -224.71% | $-10 | $-779.62K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $140.07K ▲ | $24.59M ▲ | $2.17M ▲ | $22.46M ▼ |
| Q3-2025 | $133.71K ▼ | $24.39M ▼ | $1.59M ▲ | $22.83M ▼ |
| Q2-2025 | $215.97K ▼ | $24.72M ▼ | $1.31M ▲ | $23.43M ▼ |
| Q1-2025 | $578.79K ▼ | $25.18M ▲ | $1.15M ▼ | $24.05M ▲ |
| Q4-2024 | $2.04M | $3.24M | $1.31M | $1.93M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-376.07K ▲ | $-208.35K ▲ | $-382 ▼ | $201.64K ▲ | $6.36K ▲ | $-208.73K ▲ |
| Q3-2025 | $-595.37K ▲ | $-256.74K ▲ | $-7 ▲ | $181.33K ▲ | $-82.26K ▲ | $-256.75K ▲ |
| Q2-2025 | $-623.25K ▲ | $-494.46K ▲ | $-11 ▲ | $121.02K ▼ | $-362.82K ▲ | $-494.47K ▲ |
| Q1-2025 | $-712.92K ▲ | $-1.45M ▼ | $-23M ▼ | $22.99M ▲ | $-1.46M ▼ | $-1.45M ▼ |
| Q4-2024 | $-826.6K | $-645.34K | $-1.44K | $-5.17K | $-678.79K | $-646.77K |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Energized Mineral Concentrate | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Health and Wellness Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Ionized Cal Mag | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Product | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Product Health Therapies | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
5-Year Trend Analysis
A comprehensive look at Agape ATP Corporation's financial evolution and strategic trajectory over the past five years.
The company benefits from a strong reported liquidity position, minimal debt, and a sizable equity base relative to its current scale. Its products generate positive gross margins, showing that customers are willing to pay enough to cover direct costs. Strategically, its attempt to blend wellness, lifestyle, and green energy themes offers a differentiated story that could appeal to health-conscious and sustainability-focused consumers, especially if supported by a growing ecosystem of services and partnerships.
Key risks revolve around persistent operating losses, heavy cash burn, and dependence on external equity financing. The cost structure is misaligned with current revenue, and asset quality is somewhat opaque due to large “other current assets” and limited cash. Competitive and execution risks are also high: ATPC operates in saturated, fast-moving markets against larger rivals, while simultaneously managing governance issues, dilution, and prior listing-compliance concerns. A lack of identifiable, well-funded R&D and limited evidence of proprietary technology further constrain its long-term moat.
Looking ahead, ATPC’s trajectory will largely depend on its ability to scale revenue meaningfully, rationalize its operating costs, and convert its wellness and green energy initiatives into stable, cash-generating businesses. The solid balance sheet foundation provides some runway, but continued losses and cash outflows will gradually erode that cushion if not addressed. The outlook is therefore highly execution-sensitive: there is room for upside if the strategy takes hold and financial discipline improves, but current fundamentals point to a challenging path that will require careful management and sustained access to capital.

CEO
Kok Choong How
Compensation Summary
(Year )
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2026-02-10 | Reverse | 1:50 |
| 2024-08-30 | Reverse | 1:20 |
Ratings Snapshot
Rating : C

